secwatch.observer — SEC 8-K summary
======================================

Issuer:     Alignment Healthcare, Inc. (ALHC)
CIK:        0001832466
Form:       8-K
Filed at:   2023-08-15T23:59:59+00:00
Accession:  0000950170-23-042834
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Alignment Healthcare CMO Kumar to depart Oct 1; Dr. Furman expands clinical role, $500K base
--------------------------------------------------------------------------------

- Dr. Dinesh Kumar, Chief Medical & Operating Officer, to depart Oct 1, 2023 under mutual separation agreement.
- Dr. Donald Furman, Chief Clinical Officer, assumes greater oversight; base salary set at $500,000 with 85% target bonus.
- Kumar receives accelerated vesting of $1,036,000 in equity (based on effective-date share price) plus 65,039 additional RSUs.
- Kumar also eligible for COBRA premium payments for 12 months and pro-rata 2023 bonus; vested options exercisable 90 days after Oct 1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1832466/000095017023042834/0000950170-23-042834-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1832466/000095017023042834/alhc-20230809.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-042834

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer